Erasmus Biomedical Fund

Erasmus Biomedical Fund is an independent venture capital firm based in Rotterdam, Netherlands, that invests in early-stage biotechnology and biomedical companies. The firm primarily targets commercially promising life sciences technologies, including pharmaceuticals and high-tech medical opportunities, with a specific focus on university spin-outs originating from the Rotterdam region. Operating through capital commitments from limited partners, the fund frequently collaborates with prominent life sciences co-investors such as Forbion Capital Partners, OrbiMed, and BioGeneration Ventures to syndicate early funding rounds. Its investment strategy is designed to generate venture capital returns by supporting early-stage enterprises through their initial development phases, as demonstrated by its backing of portfolio companies like arGEN-X and Therosteon. The organization maintains strong institutional ties to the local academic ecosystem, particularly Erasmus MC, to systematically identify and commercialize emerging medical research into viable corporate entities.